Natural killer T cells in pulmonary disorders. (Q37947847)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

title

Natural killer T cells in pulmonary disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

Sinisa Volarevic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

Peter Korosec

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Katarina Osolnik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

Mitja Kosnik

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

volume

105 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

S20-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22015081 AND SRC:MED&resulttype=core&format=json

Presumed guilty: natural killer T cell defects and human disease

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Raising the NKT cell family

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

NKT cells: what's in a name?

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Invariant natural killer T cells: bridging innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

The unconventional lifestyle of NKT cells

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Lysosomal glycosphingolipid recognition by NKT cells

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Ex vivo expansion of CD8 CD56 and CD8 CD56- natural killer T cells specific for MUC1 mucin

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

CD1d-restricted T cell activation by nonlipidic small molecules

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

NKT cells are phenotypically and functionally diverse

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

NKT cells and tumor immunity—a double-edged sword

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Innate immune responses support adaptive immunity: NKT cells induce B cell activation

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Functionally distinct NKT cell subsets and subtypes

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

CD4 invariant T-cell-receptor natural killer T cells in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

NKT cells in the induced sputum of severe asthmatics

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Direct activation of natural killer T cells induces airway hyperreactivity in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Association between sputum natural killer T cells and eosinophilic airway inflammation in human asthma

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

The unique role of natural killer T cells in the response to microorganisms

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Role of NKT cells in allergic asthma

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Chronic obstructive pulmonary disease: histopathology, inflammation and potential therapies

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Lung NKT cell commotion takes your breath away

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Altered effector function of peripheral cytotoxic cells in COPD.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Role of CD4 T cells in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Deficiency of pulmonary Valpha24 Vbeta11 natural killer T cells in corticosteroid-naïve sarcoidosis patients.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Expansion of pulmonary CD8 CD56 natural killer T-cells in hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Cutting edge: cytolytic effector function in human circulating CD8 T cells closely correlates with CD56 surface expression.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Th1 CD4 cells adoptively transfer experimental hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Systematic characterization of human CD8 T cells with natural killer cell markers in comparison with natural killer cells and normal CD8 T cells

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Unique subpopulations of CD56 NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Expression of C-C chemokines in bronchoalveolar lavage cells from patients with granulomatous lung diseases

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

The role of NKT cells in tumor immunity

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Natural killer T cell-mediated antitumor immune responses and their clinical applications

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Peripheral blood IFN-gamma-secreting Valpha24 Vbeta11 NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Going both ways: immune regulation via CD1d-dependent NKT cells

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021

A CD1d-dependent antagonist inhibits the activation of invariant NKT cells and prevents development of allergen-induced airway hyperreactivity

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(11)70006-3

7 January 2021